The application of combination detection of serum CA199,CA125,CEA and AFP in diagnosis of ovarian cancer
LU Guang-jia
Abstract
LU Guang-jia
Abstract
OBJECTIVE To discuss the application of combination detection of serum CA199,CA125,CEA and AFP in diagnosis of ovarian cancer.METHODS From January 2011 to December 2011,the serum CA199,CA125,CEA and AFP were detected in 67 cases with ovarian cancer patients,57 cases with benign ovarian disease and 52 healthy controls by using electrochemiluminescence method.RESULTS Serum levels of CA199,CA125,CEA and AFP were significantly elevated in ovarian cancer group than those in benign ovarian disease group and control group(P﹤0.05).There were no significant differences in CA199,CA125,CEA and AFP between benign ovarian disease group and control group(P ﹥ 0.05).The sensitive rate of combination of CA199,CA125,CEA and AFP was significantly higher than that of CA199,CA125,CEA and AFP only(P﹤ 0.05),but no significant differences in specificity(P ﹥ 0.05).CONCLUSION Serum levels of CA199,CA125,CEA and AFP are significantly increased in ovarian cancer patients,and the combination detection is good for early diagnosis of ovarian cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To discuss the application of combination detection of serum CA199,CA125,CEA and AFP in diagnosis of ovarian cancer.METHODS From January 2011 to December 2011,the serum CA199,CA125,CEA and AFP were detected in 67 cases with ovarian cancer patients,57 cases with benign ovarian disease and 52 healthy controls by using electrochemiluminescence method.RESULTS Serum levels of CA199,CA125,CEA and AFP were significantly elevated in ovarian cancer group than those in benign ovarian disease group and control group(P﹤0.05).There were no significant differences in CA199,CA125,CEA and AFP between benign ovarian disease group and control group(P ﹥ 0.05).The sensitive rate of combination of CA199,CA125,CEA and AFP was significantly higher than that of CA199,CA125,CEA and AFP only(P﹤ 0.05),but no significant differences in specificity(P ﹥ 0.05).CONCLUSION Serum levels of CA199,CA125,CEA and AFP are significantly increased in ovarian cancer patients,and the combination detection is good for early diagnosis of ovarian cancer.
Key concepts: Medicine, Ovarian cancer, Internal medicine, Cancer antigen, Gastroenterology, Disease, Oncology, Cancer